101 related articles for article (PubMed ID: 11817516)
1. The effects of antidepressant drug treatments on activator protein-1 binding activity in the rat brain.
Tamura T; Morinobu S; Okamoto Y; Kagaya A; Yamawaki S
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):375-81. PubMed ID: 11817516
[TBL] [Abstract][Full Text] [Related]
2. Restraint stress influences AP-1 and CREB DNA-binding activity induced by chronic lithium treatment in the rat frontal cortex and hippocampus.
Miller JC; Jiménez P; Mathé AA
Int J Neuropsychopharmacol; 2007 Oct; 10(5):609-19. PubMed ID: 17038209
[TBL] [Abstract][Full Text] [Related]
3. Dynamic changes in AP-1 transcription factor DNA binding activity in rat brain following administration of antidepressant amitriptyline and brain-derived neurotrophic factor.
Okamoto H; Shino Y; Hashimoto K; Kumakiri C; Shimizu E; Shirasawa H; Iyo M
Neuropharmacology; 2003 Aug; 45(2):251-9. PubMed ID: 12842131
[TBL] [Abstract][Full Text] [Related]
4. Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain.
Ozaki N; Chuang DM
J Neurochem; 1997 Dec; 69(6):2336-44. PubMed ID: 9375664
[TBL] [Abstract][Full Text] [Related]
5. Chronic antidepressant treatment down-regulates the induction of c-fos mRNA in response to acute stress in rat frontal cortex.
Morinobu S; Nibuya M; Duman RS
Neuropsychopharmacology; 1995 May; 12(3):221-8. PubMed ID: 7612155
[TBL] [Abstract][Full Text] [Related]
6. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.
Butterweck V; Winterhoff H; Herkenham M
Mol Psychiatry; 2001 Sep; 6(5):547-64. PubMed ID: 11526469
[TBL] [Abstract][Full Text] [Related]
7. Blockade by N-methyl-D-aspartate of elevation of activator protein-1 binding after stress in rat adrenal gland.
Hinoi E; Fujimori S; Yoneyama M; Yoneda Y
J Neurosci Res; 2002 Oct; 70(2):161-71. PubMed ID: 12271465
[TBL] [Abstract][Full Text] [Related]
8. Decrease in the AP-2 DNA-binding activity and in the protein expression of AP-2 alpha and AP-2 beta in frontal cortex of rats treated with lithium for 6 weeks.
Rao JS; Rapoport SI; Bosetti F
Neuropsychopharmacology; 2005 Nov; 30(11):2006-13. PubMed ID: 15827566
[TBL] [Abstract][Full Text] [Related]
9. Modulation of carbachol-stimulated AP-1 DNA binding activity by therapeutic agents for bipolar disorder in human neuroblastoma SH-SY5Y cells.
Pacheco MA; Jope RS
Brain Res Mol Brain Res; 1999 Oct; 72(2):138-46. PubMed ID: 10529472
[TBL] [Abstract][Full Text] [Related]
10. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109
[TBL] [Abstract][Full Text] [Related]
11. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
[TBL] [Abstract][Full Text] [Related]
12. Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin.
Watanabe Y; Sakai RR; McEwen BS; Mendelson S
Brain Res; 1993 Jun; 615(1):87-94. PubMed ID: 8364729
[TBL] [Abstract][Full Text] [Related]
13. Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain.
Réus GZ; Stringari RB; Ribeiro KF; Ferraro AK; Vitto MF; Cesconetto P; Souza CT; Quevedo J
Behav Brain Res; 2011 Aug; 221(1):166-71. PubMed ID: 21397634
[TBL] [Abstract][Full Text] [Related]
14. AP-1 controls the p11-dependent antidepressant response.
Chottekalapanda RU; Kalik S; Gresack J; Ayala A; Gao M; Wang W; Meller S; Aly A; Schaefer A; Greengard P
Mol Psychiatry; 2020 Jul; 25(7):1364-1381. PubMed ID: 32439846
[TBL] [Abstract][Full Text] [Related]
15. Increased tonic activation of rat forebrain 5-HT(1A) receptors by lithium addition to antidepressant treatments.
Haddjeri N; Szabo ST; de Montigny C; Blier P
Neuropsychopharmacology; 2000 Apr; 22(4):346-56. PubMed ID: 10700654
[TBL] [Abstract][Full Text] [Related]
16. Chronic pharmacological treatment with certain antidepressants alters the expression and DNA-binding activity of transcription factor AP-2.
Damberg M; Ekblom J; Oreland L
Life Sci; 2000 Dec; 68(6):669-78. PubMed ID: 11205881
[TBL] [Abstract][Full Text] [Related]
17. Effect of acute and chronic administration of methamphetamine on activator protein-1 binding activities in the rat brain regions.
Akiyama K; Ishihara T; Kashihara K
Ann N Y Acad Sci; 1996 Oct; 801():13-28. PubMed ID: 8959020
[TBL] [Abstract][Full Text] [Related]
18. Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat.
Sairanen M; O'Leary OF; Knuuttila JE; Castrén E
Neuroscience; 2007 Jan; 144(1):368-74. PubMed ID: 17049169
[TBL] [Abstract][Full Text] [Related]
19. AP-1 and Egr DNA-binding activities are increased in rat brain during ethanol withdrawal.
Beckmann AM; Matsumoto I; Wilce PA
J Neurochem; 1997 Jul; 69(1):306-14. PubMed ID: 9202324
[TBL] [Abstract][Full Text] [Related]
20. Lithium activates the c-Jun NH2-terminal kinases in vitro and in the CNS in vivo.
Yuan P; Chen G; Manji HK
J Neurochem; 1999 Dec; 73(6):2299-309. PubMed ID: 10582587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
